Chargement en cours...

Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade

The success of immune checkpoint receptor blockade has brought exciting promises for the treatment of head and neck squamous cell carcinoma (HNSCC). While patients who respond to checkpoint inhibitors tend to develop a durable response, <15% of patients with HNSCC respond to immune checkpoint inh...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Dent Res
Auteurs principaux: Heath, B.R., Michmerhuizen, N.L., Donnelly, C.R., Sansanaphongpricha, K., Sun, D., Brenner, J.C., Lei, Y.L.
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6704427/
https://ncbi.nlm.nih.gov/pubmed/31340724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0022034519864112
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!